3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
29
Rectal Neoplasms
8
Colonic Neoplasms
7
Carcinoma, Hepatocellular
7
Cholangiocarcinoma
5
Stomach Neoplasms
4
Neoplasm Metastasis
4
Neoplasms
3
Biliary Tract Neoplasms
3
Adenocarcinoma Of Esophagus
3
Ovarian Neoplasms
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Solid Tumors
1
Recurrence
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Lung Neoplasms
1
Locally Advanced Rectal Cancer
1
Locally Advanced Colorectal Carcinoma
1
Liver Neoplasms
1
Gastroesophageal Junction Adenocarcinoma
1
Gastroesophageal Adenocarcinoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Endometrial Neoplasms
1
Disease Progression
1
Colorectal Cancer Metastatic
1
Interventions
Capecitabine
6
Oxaliplatin
5
camrelizumab
2
Radiation
2
Irinotecan
2
toripalimab
1
tislelizumab
1
spartalizumab
1
sintilimab
1
Radiotherapy, Intensity-Modulated
1
Leucovorin
1
Immune Checkpoint Inhibitors
1
Folfox protocol
1
Fluorouracil
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally Advanced Rectal Cancer
×
Folfox protocol
×
1 year
×
Clear all
NCT07074353
2025-07-25
CinClare-2
Zhejiang Cancer Hospital
Phase 3
Not yet recruiting
360 enrolled